CCR4 antagonists inhibit regulatory T cell (Treg) recruitment and increase effector T cell (Teff) numbers in the tumor microenvironment potentiating an anti-tumor response

被引：0

作者：

Talay, Oezcan ^{[1
]}

Marshall, Lisa ^{[1
]}

Meleza, Cesar ^{[1
]}

Reilly, Maureen ^{[1
]}

Robles, Omar ^{[1
]}

Zibinsky, Mikhail ^{[1
]}

Okal, Abood ^{[1
]}

McKinnell, Jenny ^{[1
]}

Jacobson, Scott ^{[1
]}

Riegler, Erin ^{[1
]}

Marubayashi, Sashie ^{[1
]}

Karbarz, Emily ^{[1
]}

Chian, David ^{[1
]}

Wadsworth, Angela ^{[1
]}

Wustrow, David ^{[1
]}

Fridman, Jordan ^{[1
]}

Kassner, Paul ^{[1
]}

机构：

[1] FLX Bio Inc, San Francisco, CA USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P467

引用

页数：1

共 50 条

[1] CCR4 Antagonists Inhibit Treg Trafficking into the Tumor Microenvironment
Ketcham, John M.
Marshall, Lisa A.
Talay, Oezcan
ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (10): : 953 - 955
[2] A novel CCR4 antagonist induces potent anti-tumor response through inhibition of Treg migration into the tumor microenvironment
Nair, Rashmi
Abbineni, Chandrasekhar
Talluri, Krishna Chaitanya
Dhudashiya, Amit A.
Aravind, A. B.
Kumar, Naveen R.
Ramya, R.
Balasubramanyam, D.
Obanna, Pathur
Madhaiyan, Rabin
Samiulla, D. S.
Daginakatte, Girish
Narayanan, Kishore
Nellore, Kavitha
Chelur, Shekar
Samajdar, Susanta
Ramachandra, Murali
CANCER RESEARCH, 2024, 84 (06)
[3] Potent and selective C-C chemokine receptor (CCR4) antagonists potentiate anti-tumor immune responses by inhibiting regulatory T cells (Treg)
Talay, Oezcan
Marshall, Lisa
Meleza, Cesar
Reilly, Maureen K.
Robles, Omar
Zibisky, Mikhail
Okal, Abood
Seitz, Lisa
McKinnell, Jenny
Jacobson, Scott
Riegler, Erin
Karbaz, Emily
Chian, David
Wadsworth, Angela
Kassner, Paul
Wustrow, David
Fridman, Jordan S.
CANCER RESEARCH, 2017, 77
[4] TUMOR MICROENVIRONMENT INFILTRATING MYELOID DERIVED SUPPRESSOR CELLS INHIBIT ANTI-TUMOR T CELL RESPONSES
Kamran, Neha
Ayala, Mariela
Li, Youping
Assi, Hikmat
Candolfi, Marianela
Dzaman, Marta
Lowenstein, Pedro
Castro, Maria
NEURO-ONCOLOGY, 2014, 16
[5] Selective regulatory T cell depletion by anti-CCR8 antibody enhances anti-tumor immunity
Ohkura, Naganari
Yasumizu, Yoshiaki
Hagiwara, Masaki
Kidani, Yujiro
Fuji, Hiroaki
Iwaisako, Keiko
Nakamura, Yamami
Sakaguchi, Shimon
CANCER SCIENCE, 2025, 116 : 806 - 806
[6] INTERFERON-α AUGMENTS REGULATORY T CELL (TREG) DEPLETION TO BOOST ANTI-TUMOR IMMUNITY AND CLINICAL RESPONSE IN OVARIAN CANCER
Thibodeaux, S.
Wall, S.
Ludwig, S.
Kious, M.
Lai, A.
Jeansonne, D.
Sun, X.
Lomada, D.
Daniel, B.
Curiel, T.
JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (02) : 483 - 483
[7] Dendritic Cells in Shaping Anti-Tumor T Cell Response
Mazzoccoli, Luciano
Liu, Bei
CANCERS, 2024, 16 (12)
[8] Manipulation of T cell activation in the anti-tumor immune response
Hurwitz, AA
Leach, DR
van Elsas, A
Townsend, SE
Allison, JP
BIOLOGY OF TUMORS, 1998, : 213 - 222
[9] Impaired Anti-Tumor T cell Response in Hepatocellular Carcinoma
Chaoul, Nada
Mancarella, Serena
Lupo, Luigi
Giannelli, Gianluigi
Dituri, Francesco
CANCERS, 2020, 12 (03)
[10] The immunoreceptor TIGIT regulates anti-tumor and anti-viral T cell effector function
Grogan, J.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 327 - 327

← 1 2 3 4 5 →